These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8694104)

  • 21. Triamcinolone acetonide-induced ocular hypertension.
    Jonas JB; Sauder G; Budde WM; Spandau UH; Kamppeter BA; Harder B
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):247-50. PubMed ID: 16910865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
    Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
    J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide.
    Heatley CJ; Lim KS; Siriwardena D; Barton K
    Acta Ophthalmol Scand; 2006 Oct; 84(5):712-3. PubMed ID: 16965510
    [No Abstract]   [Full Text] [Related]  

  • 24. Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis.
    Salek SS; Leder HA; Butler NJ; Gan TJ; Dunn JP; Thorne JE
    Ocul Immunol Inflamm; 2013 Aug; 21(4):257-63. PubMed ID: 23617776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of intraocular corticosteroids.
    Kiernan DF; Mieler WF
    Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure alterations following intravitreal triamcinolone acetonide.
    Rhee DJ; Peck RE; Belmont J; Martidis A; Liu M; Chang J; Fontanarosa J; Moster MR
    Br J Ophthalmol; 2006 Aug; 90(8):999-1003. PubMed ID: 16597664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
    Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
    Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA; Gonzales CR; Schwartz SD
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
    Chan LW; Hsu WC; Hsieh YT
    J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
    Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
    Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Common Procedure With an Uncommon Pathology: Triamcinolone Acetonide Eyelid Injection.
    Wolkow N; Jakobiec FA; Hatton MP
    Ophthalmic Plast Reconstr Surg; 2018; 34(3):e72-e73. PubMed ID: 29346171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis.
    Kuo HK; Lai IC; Fang PC; Teng MC
    Chang Gung Med J; 2005 Feb; 28(2):85-9. PubMed ID: 15880983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of uveitis-associated ocular hypertension and glaucoma.
    Kesav N; Palestine AG; Kahook MY; Pantcheva MB
    Surv Ophthalmol; 2020; 65(4):397-407. PubMed ID: 31816329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.